Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2026-01-22 @ 9:14 AM
Study NCT ID:
NCT06526104
Status:
RECRUITING
Last Update Posted:
2024-12-09
First Post:
2024-07-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas with Child-Pugh-B Cirrhosis
Sponsor:
The University of Texas Health Science Center at San Antonio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-02
Start Date Type:
ACTUAL
Primary Completion Date:
2027-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-23
First Submit QC Date:
None
Study First Post Date:
2024-07-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-04
Last Update Post Date:
2024-12-09
Last Update Post Date Type:
ACTUAL